Prognostic significance of cyclin D1 and p16 in patients with intermediate‐risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy
View Full Paper
Ask AI
Bookmark
Share
Abstract
An assessment of cyclin D1 and p16 levels might be of clinical use in defining subgroups of patients with poor prognosis.
Discussion
No takes yet. Share an insight, caveat, or question.